Revenue doubled year-over-year to $2 million in Q2 2026, but net loss widened to $270 million due to higher R&D and SG&A expenses. Liquidity remains strong with $136 million in cash and $1,081 million in investments, and management expects sufficient resources for at least twelve months.Original do…
Revenue doubled year-over-year to $2 million in Q2 2026, but net loss widened to $270 million due to higher R&D and SG&A expenses. Liquidity remains strong with $136 million in cash and $1,081 million in investments, and management expects sufficient resources for at least twelve months.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
